ABSTRACT
Background Melbourne, Australia, recorded one of the longest and most stringent pandemic lockdowns in 2020, which was associated with an increase in preterm stillbirths among singleton pregnancies. Twin pregnancies may be particularly susceptible to the impacts of pandemic disruptions to maternity care due to their higher background risk of adverse perinatal outcomes.
Objective To compare the rates of adverse perinatal outcomes in twin pregnancies exposed and unexposed to lockdown restrictions in Melbourne.
Study Design Multicenter retrospective cohort study of all twin pregnancies birthing in public maternity hospitals in Melbourne. We compared perinatal outcomes between a pre- pandemic group (‘unexposed’) and two lockdown-exposed groups: exposure 1 from 22 March 2020 to 21 March 2021 and exposure 2 from 22 March 2021 to 27 March 2022. We analyzed routinely-collected maternity data on all twin births ≥20 weeks where outcomes were available for both infants. The primary outcomes were rates of preterm birth<37 weeks and all-cause stillbirth. Multivariable log-binomial regression models were used to compare perinatal outcomes between the pre-pandemic group and women in whom weeks 20+0 to 40+0 of their pregnancy occurred entirely during each lockdown-exposure period. Perinatal outcomes were calculated per infant; maternal outcomes were calculated per pregnancy.
Results We included 2267 women birthing twins. Total preterm births<37 weeks were significantly lower in the exposure 1 group compared with the pre-pandemic group (63.1% vs 68.3% respectively; adjusted risk ratio, aRR 0.92 95% CI 0.87-0.98, p=0.01). This was mainly driven by fewer spontaneous preterm births (18.9% vs 20.3%; aRR 0.95 95%CI 0.90- 0.99, p=0.04) and a trend to fewer iatrogenic preterm births (44.1% vs 48.1%; aRR 0.97 95%CI 0.92-1.03, p=0.39). There were also significantly lower rates of preterm birth<34 weeks in the exposure 1 group compared with the pre-pandemic group (19.9% vs 23.0%, aRR 0.93 95%CI 0.89-0.98 p=0.01). Total iatrogenic births for fetal compromise were significantly lower (13.4% vs 20.4%; aRR 0.94 95%CI 0.89–0.98, p=0.01). There were fewer special care nursery admissions (38.5% vs 43.4%; aRR 0.91 95%CI 0.87-0.95, p<0.001). There was no associated difference in all-cause stillbirths (1.5% vs 1.6%; aRR 1.00 95%CI 0.99-1.01, p=0.82), birthweight<3rd centile (5.7% vs 6.0%; aRR 1.00, 95%CI 0.98-1.02 p=0.74) or neonatal intensive care unit admissions in the exposure 1 group compared to the pre-pandemic group. In contrast, when comparing the pre-pandemic group with exposure 2 group, there was no significant difference in the rates of preterm birth<37 or <34 weeks. However, during exposure 2 the rate of preterm birth<28 weeks was significantly higher (7.2% vs 4.8%; aRR 1.03 95%CI 1.01-1.05, p=0.04) and infants were more likely to be admitted to a neonatal intensive care unit (25.0% vs 19.6%; aRR 1.06 95%CI 1.03-1.10, p<0.0001) compared with the pre-pandemic period.
Conclusions Melbourne’s first lockdown-exposure period was associated with fewer twin preterm births<34 and <37 weeks without significant differences in stillbirths or adverse newborn outcomes. These lower rates were not sustained in the second exposure period. Pandemic conditions may provide important lessons for future antenatal care of twin pregnancies, including prevention of preterm birth and optimal timing of birth.
Competing Interest Statement
LH has received research funding from Ferring Pharmaceuticals outside the scope of this work. BWM is a consultant for Guerbet, and has received research grants from Guerbet and Merck. KRP has received consultancy fees from Janssen. DLR has received fees from General Electric, the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) and Alexion for lectures and participation in advisory boards, all unrelated to this work. All other authors declare no competing interests.
Funding Statement
The Collaborative Maternity and Newborn Dashboard (CoMaND) for the COVID-19 pandemic was funded by the Norman Beischer Medical Research Foundation, and the University of Melbourne Department of Obstetrics and Gynaecology. LH, KRP and BWM are supported by National Health and Medical Research Council investigator grants (GNT1196010, GNT2009765 and GNT11766437). The funding bodies had no role in any aspects of the design or conduct of this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Austin Health gave ethical approval for this work (HREC/64722/Austin-2020) Ethics committee of Mercy Health gave ethical approval for this work (ref. 2020-031)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Disclosure statement: The authors report no conflict of interest.
Funding: The Collaborative Maternity and Newborn Dashboard (CoMaND) for the COVID- 19 pandemic was funded by the Norman Beischer Medical Research Foundation, and the University of Melbourne Department of Obstetrics and Gynaecology. LH, KRP and BWM are supported by National Health and Medical Research Council investigator grants (GNT1196010, GNT2009765 and GNT11766437). The funding bodies had no role in any aspects of the design or conduct of this study.
Paper presentation information: The findings of our study were presented at the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Scientific Symposium February-March 2022 Melbourne, Australia and at the Perinatal Society of Australia and New Zealand (PSANZ) Annual Congress March 2023 Melbourne, Australia as poster presentations.
Data Availability
All data produced in the present study are available upon reasonable request to the authors